cv
Tanveer Ahmad Wani
Bio
My research interests lie at the intersection of investigation of the mechanism of protein-drug interactions using experimental, molecular docking, and bioinformatics approaches. In addition, I am also interested in analytical method development, bioavailability and bioequivalence of drugs.
One of my primary research interests is investigating the mechanism of protein-drug interactions. Understanding the molecular mechanisms underlying protein-drug interactions is crucial for developing safe and effective therapies. I am interested in using biophysical methods, computational techniques such as molecular docking and bioinformatics to predict and analyze protein-drug interactions. By combining experimental and computational approaches, we can gain a better understanding of the molecular mechanisms underlying drug-protein interactions.
Another area of interest for me is analytical method development. I am interested in developing sensitive analytical methods to quantify drugs in biological matrices. These methods can provide insights into drug pharmacokinetics and pharmacodynamics and are crucial for optimizing drug dosing regimens and improving therapeutic outcomes.
I am also interested in studying the bioavailability and bioequivalence of drugs. I have worked for several years in the clinical setup of clinical pharmacology unit for conducting bioequivalence studies. I have experience in designing, executing and quality control of bioequivalence studies, as well as in conducting other types of clinical trials. This experience includes developing study protocols, recruiting and screening study participants, administering study drugs, and collecting and analyzing study data.
Overall, my research interests in analytical method development, bioavailability and bioequivalence, and investigation of the mechanism of protein-drug interactions are driven by the need to develop safer and more effective drugs. By combining experimental and computational approaches, we can gain a better understanding of the molecular mechanisms underlying drug-protein interactions and optimize drug dosing regimens to improve therapeutic outcomes.
One of my primary research interests is investigating the mechanism of protein-drug interactions. Understanding the molecular mechanisms underlying protein-drug interactions is crucial for developing safe and effective therapies. I am interested in using biophysical methods, computational techniques such as molecular docking and bioinformatics to predict and analyze protein-drug interactions. By combining experimental and computational approaches, we can gain a better understanding of the molecular mechanisms underlying drug-protein interactions.
Another area of interest for me is analytical method development. I am interested in developing sensitive analytical methods to quantify drugs in biological matrices. These methods can provide insights into drug pharmacokinetics and pharmacodynamics and are crucial for optimizing drug dosing regimens and improving therapeutic outcomes.
I am also interested in studying the bioavailability and bioequivalence of drugs. I have worked for several years in the clinical setup of clinical pharmacology unit for conducting bioequivalence studies. I have experience in designing, executing and quality control of bioequivalence studies, as well as in conducting other types of clinical trials. This experience includes developing study protocols, recruiting and screening study participants, administering study drugs, and collecting and analyzing study data.
Overall, my research interests in analytical method development, bioavailability and bioequivalence, and investigation of the mechanism of protein-drug interactions are driven by the need to develop safer and more effective drugs. By combining experimental and computational approaches, we can gain a better understanding of the molecular mechanisms underlying drug-protein interactions and optimize drug dosing regimens to improve therapeutic outcomes.